Vor Biopharma (VOR) Non-Current Assets (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Non-Current Assets data on file, last reported at $6.0 million in Q1 2026.

• On a quarterly basis, Non-Current Assets fell 86.58% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $16.2 million, a 91.52% decrease from a year earlier, with the FY2025 full-year figure at $6.0 million, down 87.02% from the prior year.
• Non-Current Assets for Q1 2026 stood at $6.0 million, down from $6.0 million in the prior quarter.
• Over the last five years, Non-Current Assets for VOR reached as high as $65.8 million in Q2 2022 and fell as low as $444000.0 in Q2 2025.
• Historically, Non-Current Assets has averaged $43.2 million across 5 years, with a median of $51.3 million in 2024.
• Across the five-year window, Non-Current Assets soared 154.16% in 2022 and slumped 99.14% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $62.4 million in 2022, then dropped by 8.16% to $57.3 million in 2023, then fell by 19.08% to $46.4 million in 2024, then sank by 87.02% to $6.0 million in 2025, then retreated by 0.88% to $6.0 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $6.0 million in Q1 2026, $6.0 million in Q4 2025, and $3.8 million in Q3 2025.